SCHEMBL31015960

SCHEMBL31015960

COC(=O)c1sc2cc(Cl)ccc2c1I

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 2/20 0.51
▸ MCL1 Q07820 2/20 0.51
▸ BCKDK O14874 1/20 0.51
▸ NPC1 O15118 4/20 0.46
▸ RAB9A P51151 4/20 0.46
▸ MAPT P10636 6/20 0.45
▸ KDM4E B2RXH2 5/20 0.45
▸ CASP3 P42574 1/20 0.45
▸ SENP8 Q96LD8 1/20 0.45
▸ SENP7 Q9BQF6 1/20 0.45
▸ SENP6 Q9GZR1 1/20 0.45
▸ NR4A2 P43354 2/20 0.43
▸ MAPK1 P28482 5/20 0.43
▸ LMNA P02545 3/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ GAA P10253 2/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ PRNP P04156 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ PPARG P37231 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25212927 1.00 RXFP1 (0.51) RXFP1MCL1BCKDKNPC1RAB9A
SCHEMBL25575157 0.85 MCL1 (0.48) RXFP1MCL1BCKDKNPC1RAB9A
SCHEMBL2578736 0.84 RXFP1 (0.53) RXFP1MCL1BCKDKNPC1RAB9A
SCHEMBL15619136 0.84 MCL1 (0.53) RXFP1MCL1BCKDKNPC1RAB9A
SCHEMBL31015908 0.82 BCKDK (0.49) MCL1BCKDKNPC1RAB9AMAPT
SCHEMBL31015931 0.82 KDM4E (0.64) RXFP1MCL1BCKDKNPC1RAB9A
SCHEMBL31015986 0.82 RXFP1 (0.51) RXFP1MCL1BCKDKNPC1RAB9A
SCHEMBL25257143 0.82 RXFP1 (0.51) RXFP1MCL1BCKDKNPC1RAB9A
SCHEMBL25211925 0.82 BCKDK (0.49) MCL1BCKDKNPC1RAB9AMAPT
SCHEMBL8142110 0.82 KDM4E (0.64) RXFP1MCL1BCKDKNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118451066-A 3-Phenyl-1-benzothiophene-2-carboxylic acid derivatives as inhibitors of branched alpha ketoacid dehydrogenase kinase for the treatment of diabetes, kidney disease, NASH and heart failure 辉瑞大药厂 2024-08-06 — — CN disclosed
Send feedback